• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.

作者信息

Targher Giovanni, Day Christopher P, Bonora Enzo

机构信息

Section of Endocrinology and Metabolism, Department of Medicine, University of Verona, Verona, Italy.

出版信息

N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.

DOI:10.1056/NEJMra0912063
PMID:20879883
Abstract
摘要

相似文献

1
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
2
[Relationship between carotid atherosclerosis and nonalcoholic fatty liver disease].颈动脉粥样硬化与非酒精性脂肪性肝病之间的关系
Zhonghua Gan Zang Bing Za Zhi. 2009 Nov;17(11):875-6.
3
[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease].非酒精性脂肪性肝病作为心血管疾病的一个危险因素
Korean J Hepatol. 2008 Mar;14(1):1-3. doi: 10.3350/kjhep.2008.14.1.1.
4
[Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis].非酒精性脂肪性肝病作为心血管疾病的危险因素：非酒精性脂肪性肝病与颈动脉粥样硬化的关系
Korean J Hepatol. 2008 Mar;14(1):77-88. doi: 10.3350/kjhep.2008.14.1.77.
5
Perspective: nonalcoholic fatty liver disease and cardiovascular risk.观点：非酒精性脂肪性肝病与心血管风险。
Curr Opin Lipidol. 2013 Feb;24(1):1-3. doi: 10.1097/MOL.0b013e32835c0834.
6
Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.意大利南部青少年人群中心血管危险因素、非酒精性脂肪性肝病与颈动脉内膜中层厚度的关系。
Am J Epidemiol. 2010 Jun 1;171(11):1195-202. doi: 10.1093/aje/kwq073. Epub 2010 May 9.
7
Disorders of coagulation and hemostasis in abdominal obesity: emerging role of fatty liver.腹部肥胖中的凝血和止血紊乱：脂肪肝的新作用。
Semin Thromb Hemost. 2010 Feb;36(1):41-8. doi: 10.1055/s-0030-1248723. Epub 2010 Apr 13.
8
Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.异位脂肪、胰岛素抵抗和非酒精性脂肪性肝病：对心血管疾病的影响。
Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1155-61. doi: 10.1161/ATVBAHA.114.303034. Epub 2014 Apr 17.
9
[The association of cardiovascular risk factors with nonalcoholic fatty liver disease in health checkup examinees].[健康体检者中心血管危险因素与非酒精性脂肪性肝病的关联]
J Prev Med Public Health. 2008 Nov;41(6):407-12. doi: 10.3961/jpmph.2008.41.6.407.
10
The interactions of nonalcoholic fatty liver disease and cardiovascular diseases.非酒精性脂肪性肝病与心血管疾病的相互作用。
Clin Liver Dis. 2014 Feb;18(1):233-48. doi: 10.1016/j.cld.2013.09.014. Epub 2013 Oct 25.

引用本文的文献

1
Body muscle mass versus fat mass: gender-specific associations with NAFLD and liver fibrosis.身体肌肉量与脂肪量：与非酒精性脂肪性肝病及肝纤维化的性别特异性关联
Lipids Health Dis. 2025 Sep 9;24(1):278. doi: 10.1186/s12944-025-02694-4.
2
Association between questionnaire- and accelerometer-measured physical activity and incidence of cardiovascular disease in subjects with metabolic dysfunction-associated steatotic liver disease.代谢功能障碍相关脂肪性肝病患者中，通过问卷和加速度计测量的身体活动与心血管疾病发病率之间的关联。
Am J Prev Cardiol. 2025 Aug 22;23:101272. doi: 10.1016/j.ajpc.2025.101272. eCollection 2025 Sep.
3
Skeletal Muscle and Cardiovascular Health.
骨骼肌与心血管健康。
Adv Exp Med Biol. 2025;1478:631-659. doi: 10.1007/978-3-031-88361-3_26.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease: A Silent Driver of Cardiovascular Risk and a New Target for Intervention.代谢功能障碍相关脂肪性肝病：心血管风险的隐匿驱动因素及新的干预靶点
Int J Mol Sci. 2025 Aug 21;26(16):8081. doi: 10.3390/ijms26168081.
5
Impact of smoking and physical activity on cardiovascular outcomes in type 2 diabetes across steatotic liver disease categories.吸烟和体育活动对不同类型脂肪性肝病的2型糖尿病患者心血管结局的影响。
Sci Rep. 2025 Aug 23;15(1):31029. doi: 10.1038/s41598-025-16750-7.
6
Association between metabolic dysfunction-associated steatotic liver disease and cardiovascular disease: New perspectives.代谢功能障碍相关脂肪性肝病与心血管疾病之间的关联：新观点
Medicine (Baltimore). 2025 Aug 15;104(33):e43952. doi: 10.1097/MD.0000000000043952.
7
Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD.多面手人类抗原R（HuR）：肝脏代谢和代谢相关脂肪性肝病中的关键角色
Livers. 2025 Sep;5(3). doi: 10.3390/livers5030033. Epub 2025 Jul 21.
8
Elimination of hepatocyte-derived DPP4 downregulates cardiac immune- and collagen-related genes but does not alter cardiac function in aged male mice.消除肝细胞衍生的二肽基肽酶4可下调老年雄性小鼠心脏中与免疫和胶原蛋白相关的基因，但不改变心脏功能。
Physiol Rep. 2025 Aug;13(15):e70453. doi: 10.14814/phy2.70453.
9
Identification of biomarkers between coronary artery disease and non-alcoholic steatohepatitis: a combination of bioinformatics and machine learning.冠状动脉疾病与非酒精性脂肪性肝炎之间生物标志物的鉴定：生物信息学与机器学习相结合
Front Genet. 2025 Jul 17;16:1573621. doi: 10.3389/fgene.2025.1573621. eCollection 2025.
10
Associations among serum FGF21 levels, inflammation, and metabolic dysfunction-associated steatotic liver disease: mediation analyses in a Chinese community-based population.血清成纤维细胞生长因子21水平、炎症与代谢功能障碍相关脂肪性肝病之间的关联：基于中国社区人群的中介分析
Endocr Connect. 2025 Aug 7;14(8). doi: 10.1530/EC-25-0351. Print 2025 Aug 1.